Completed
Calcium Levels and Intact Parathyroid Hormone Relationship in Adults With Repaired or Palliated Conotruncal Cardiac Defects
What is being collected
Drug Data
+ drug Data
Drug
Who is being recruted
Congenital Abnormalities+28
+ Abnormalities, Multiple
+ Cardiovascular Diseases
Over 18 Years
How is the trial designed
Observational
Study Start: July 1995
Summary
Principal SponsorNational Center for Research Resources (NCRR)
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
Study start date: July 1, 1995
Actual date on which the first participant was enrolled.PROTOCOL OUTLINE: Patients are given sodium citrate over a 2 hour infusion on day 1. Blood is drawn at times -30, -15, 0, and every 10 minutes thereafter during the infusion. On day 2, patients are given calcium gluconate over a 2 hour infusion. Blood is drawn at times -30, -15, 0, and every 10 minutes thereafter during the infusion.
Principal SponsorNational Center for Research Resources (NCRR)
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
150 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Congenital AbnormalitiesAbnormalities, MultipleCardiovascular DiseasesHeart DiseasesHeart Valve DiseasesHemic and Lymphatic DiseasesLymphatic DiseasesMusculoskeletal AbnormalitiesMusculoskeletal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesParathyroid DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsVentricular Outflow ObstructionCardiovascular AbnormalitiesCraniofacial AbnormalitiesDisease AttributesChromosome DisordersLymphatic AbnormalitiesVascular Malformations22q11 Deletion SyndromeDiGeorge SyndromeEndocrine System DiseasesHeart Defects, CongenitalHypoparathyroidismPulmonary Valve StenosisRespiratory Tract DiseasesTetralogy of FallotPulmonary AtresiaGenetic Diseases, InbornRare Diseases
Criteria
Diagnostically shown repaired or palliated conotruncal cardiac defects, including tetralogy of Fallot with pulmonary stenosis or pulmonary atresia, truncus arteriosus, or interrupted aortic arch type B
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has no location dataSave this study to your profile to know when the location data is available.
CompletedNo study centers